業聚醫療(6929.HK):旗下荷蘭高容量物流中心正式啟用
業聚醫療(6929.HK),一家專營經皮冠狀動脈介入治療(PCI)及經皮腔內血管成形術(PTA)手術介入器械的全球主要醫療器械製造商,集團旗下位於荷蘭的超現代物流中心今天正式啟用。這次集團投資建設新倉庫旨在應付生產方面的需求增長,並滿足對物流和倉儲能力日益殷切的需求,此舉不僅彰顯了集團在客户服務、質量合規、數碼化及可持續發展方面的承諾與投入,相信亦能顯著推動其荷蘭荷佛拉肯生產基地的增長及發展。
該物流中心佔地逾1200平方米,可儲存超過20萬件對温度敏感的成品。該設施同時配備高位貨架,為現時倉儲所需及日後進一步擴展提供充裕空間。
業聚醫療董事長、執行董事兼首席執行官錢永勛先生在物流中心啟用儀式上表示:“此項投資提升及鞏固了我們的綜合供應鏈,全面配合集團的戰略願景。隨着我們成功收購 eucatech AG,引入藥物洗脱球囊等創新醫療器械,豐富了產品組合。這擴張業務的舉措不僅重申了我們致力為客户提供卓越產品的承諾,加強我們與客户的緊密聯繫,更明確地體現了我們全心全意服務客户的宗旨。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.